Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.

@article{Gu2018ClinicalBO,
  title={Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.},
  author={Bin Gu and Huijie Miao and J Zhang and Jiong Yu Hu and Wei Zhou and Weiting Gu and Wei Wang and Guang Ning},
  journal={Diabetes & metabolism},
  year={2018},
  volume={44 4},
  pages={
          341-345
        }
}
Type 1 diabetes (T1D) is characterized by severe damage to pancreas islet function through immunological attack; therefore, it is also called 'insulin-dependent diabetes'. The present study aimed to evaluate the safety and clinical efficacy of autologous haematopoietic stem cell transplantation (AHSCT) in adolescent patients with newly diagnosed T1D. A phase-II prospective, parallel-assignment, non-randomized trial was conducted from March 2008 to December 2011 with 40 T1D patients, of whom 20… CONTINUE READING